Inventor

OCHSE MICHAEL

DE40 patents

⚠️ This page may combine multiple inventors who share the name “OCHSE MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

OCHSE MICHAEL

ABBVIE DEUTSCHLAND

Substituted pyrazolopyrimidines and method of use

Inhibitor compounds of phosphodiesterase type 10A

Inhibitor compounds of phosphodiesterase type 10A

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

Inhibitor compounds of phosphodiesterase type 10A

Inhibitor compounds of phosphodiesterase type 10A

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

Inhibitor compounds of phosphodiesterase type 10A

Inhibitor compounds of phosphodiesterase type 10A

Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy

Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors

Substituted pyrazolopyrimidines and method of use

Inhibitor compounds of phosphodiesterase type 10A

Fused (hetero)cyclic compounds as S1P modulators

Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy

AMBERG WILHELM

4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

Heterocyclic compounds and their use as binding partners for 5-HT5 receptors

5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors

Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy

Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-HT5-receptors

POHLKI FRAUKE

Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

LANGE UDO

Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy

Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy

NETZ ASTRID

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

ABBOTT GMBH & CO KG

Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10A

Inhibitor compounds of phosphodiesterase type 10A

ABBVIE INC

Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use

Fused heterocyclic compounds as S1P modulators

OCHSE MICHAEL

Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy

GENESTE HERVE

Inhibitor compounds of phosphodiesterase type 10A

BASF AG

Method for producing isocyanates

ABBOTT LAB

Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

BRAUN AVITUM AG

Extracorporeal blood treatment machine comprising a poka-yoke for a pressure sensor